BDX Q2 2020 Earnings — Becton, Dickinson and Company Revenue & Financial Results | Market Cap Arena

BDXBecton, Dickinson and Company

$59B

Q2 2020 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$4.3B+1.4% YoY

Gross Profit

$1.7B40.7% margin

Operating Income

$370M8.7% margin

Net Income

$183M4.3% margin

EPS (Diluted)

$0.53

QoQ Revenue Growth

+0.7%

Cash Flow

Operating Cash Flow

$482M

Free Cash Flow

$260M

Stock-Based Comp.

$59M

Balance Sheet

Total Assets

$53.5B

Total Liabilities

$32.6B

Stockholders' Equity

$21.0B

Cash & Equivalents

$2.4B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4.3B	$4.2B	+1.4%
Gross Profit	$1.7B	$2.0B	-12.2%
Operating Income	$370M	$136M	+172.1%
Net Income	$183M	$20M	+815.0%

Revenue Segments

Medical

$2.2B51%

Life Sciences

$1.1B26%

Interventional

$990M23%

Geographic Segments

UNITED STATES

$2.4B57%

Non-US

$1.8B43%